Home LiteratureArticle Details
PMID: 14969489 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach.

Biometrics ·Vol. 59 ·No. 4 ·2003-12-00 ·Pages 1089-98

Rosner B, Glynn RJ, Lee ML

Abstract

The Wilcoxon rank sum test is frequently used in statistical practice for the comparison of measures of location when the underlying distributions are far from normal or not known in advance. An assumption of the ordinary rank sum test is that individual sampling units are independent. In many ophthalmologic clinical trials, the Early Treatment for Diabetic Retinopathy Scale (ETDRS) is a principal endpoint used for measuring the level of diabetic retinopathy. This is an ordinal scale, and it is natural to consider the Wilcoxon rank sum test for the comparison of the level of diabetic retinopathy between treatment groups. However, under this design, unlike the usual Wilcoxon rank sum test, the subject is the unit of randomization, but the eye is the unit of analysis. Furthermore, a person will tend to have different, but correlated, ETDRS scores for fellow eyes. Thus, we propose a correction to the variance of the Wilcoxon rank sum statistic that accounts for clustering effects and that can be used for both balanced (same number of subunits per cluster) or unbalanced (different number of subunits per cluster) data, both in the presence or absence of ties, with p-value adjusted accordingly. In this article, we present large-sample theory and simulation results for this test procedure and apply it to diabetic retinopathy data from type I diabetics in the Sorbinil Retinopathy Trial.

MeSH Terms
Biometry/methods Cluster Analysis Controlled Clinical Trials as Topic Diabetic Retinopathy/drug therapy Humans Imidazoles/therapeutic use Imidazolidines Models, Statistical Statistics, Nonparametric
Chemicals
Imidazoles Imidazolidines sorbinil
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rosner Bernard
Channing Laboratory, Harvard Medical School, 181 Longwood Avenue, Boston, Massachusetts, USA. bernard.rosner@channing.harvard.edu
Glynn Robert J
Lee Mei-Ling Ting
Article Info
Journal
Biometrics
Abbr.
Biometrics
ISSN
0006-341X
Published
2003-12-00
Pages
1089-98
Language
English
Region
United States
NLM ID
0370625
Subset
IM
Grants
NEI NIH HHS · EY12269 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com